Nausheen Ahmed, Associate Professor of Medicine, Medical Director of BMT Survivorship Program at The University of Kansas, shared a post on LinkedIn:
“Introducing the Next ICE-T Congress — April 2026 | Charlotte, NC
We are excited to announce the 2nd National ICE-T (Immune Cell Effector Therapy) Congress, taking place in April 2026 in Charlotte, North Carolina.
ICE-T brings together clinicians, researchers, and healthcare professionals for a practical, clinically focused deep-dive into immune effector therapies—bridging science, real-world practice, and future directions.
From CAR-T and bispecifics to evolving applications in myeloma, lymphoma, and solid tumors, ICE-T is designed as a practical guide with real-world insights on practice management, toxicity mitigation, and the latest advances shaping patient care.
The ICE-T Series Directors (Zahra Mahmoudjafari, Al-Ola Abdallah and myself) and the Chairs ( Shebli Atrash and Barry Paul) – warmly welcome you to join this collaborative and forward-thinking event as we collectively advance the field of immune cell therapies.
To view the agenda and register, visit.”
More posts featuring Nausheen Ahmed.